The next CRE disruptor: Pharmacology incubator labs
Drug makers and other major life sciences companies are working with savvy CRE professionals to bring new life sciences incubator spaces into the market in…
Vetter Pharma
German pharmaceutical service provider plans to develop a $320M manufacturing facility in Des Plaines
Vetter plans to develop a $320 million state of the art facility in Des Plaines, the first of its kind manufacturing facility outside of Germany,…